Loss of SFRP4 alters body size, food intake, and energy expenditure in diet-induced obese male mice

Endocrinology (United States)

Volumn 156, Issue 12, 2015, Pages 4502-4510

  Mastaitis, Jason ^a   Eckersdorff, Mark ^a   Min, Soo ^a   Xin, Yurong ^a   Cavino, Katie ^a   Aglione, Johnpaul ^a   Okamoto, Haruka ^a   Na, Erqian ^a   Stitt, Trevor ^a   Dominguez, Melissa G ^a   Schmahl, Jennifer P ^a   Lin, Calvin ^a   Gale, Nicholas W ^a   Valenzuela, David M ^a   Murphy, Andrew J ^a   Yancopoulos, George D ^a   Gromada, Jesper ^a  

^a REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD4 ANTIGEN; CYSTEINE RICH PROTEIN 1; EPITHELIAL MEMBRANE PROTEIN 1; GLUCOSE; INSULIN; MESSENGER RNA; OSTEOPONTIN; OUTER DENSE FIBER OF SPERM TAIL 3B PROTEIN; SCLEROSTIN; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 3; SECRETED FRIZZLED RELATED PROTEIN 4; SH3 BINDING DOMAIN GLUTAMIC ACID RICH PROTEIN; SOLUTE CARRIER FAMILY 35, MEMBER D3 PROTEIN; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; WNT4 PROTEIN; GLUCOSE BLOOD LEVEL; ONCOPROTEIN; SFRP4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY SIZE; BODY WEIGHT; BONE DENSITY; BONE LENGTH; BONE MASS; BONE MINERAL; CELL EXPANSION; CONTROLLED STUDY; DIET INDUCED OBESITY; EMBRYO; ENERGY EXPENDITURE; FAT INTAKE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYDRODYNAMICS; INSULIN BLOOD LEVEL; INSULIN TOLERANCE TEST; INTRACELLULAR SIGNALING; LIPID DIET; MALE; METABOLIC RATE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; SPINE; WEIGHT GAIN; ANIMAL; EATING; ENERGY METABOLISM; FEEDING BEHAVIOR; GENE TARGETING; GENETICS; GLUCOSE TOLERANCE TEST; HEK293 CELL LINE; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; OBESITY; WNT SIGNALING PATHWAY;

ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; BODY SIZE; BONE DENSITY; DIET, HIGH-FAT; EATING; ENERGY METABOLISM; FEEDING BEHAVIOR; GENE KNOCK-IN TECHNIQUES; GLUCOSE TOLERANCE TEST; HEK293 CELLS; HOMEOSTASIS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, KNOCKOUT; OBESITY; PROTO-ONCOGENE PROTEINS; WNT SIGNALING PATHWAY; X-RAY MICROTOMOGRAPHY;

EID: 84948176074     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1257     Document Type: Article

References (45)

1. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 2003;116:2627-2634.
2. Ehrlund A, Mejhert N, Lorente-Cebrian S, et al. Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J Clin Endocrinol Metab. 2013;98:E503-E508.
3. Liu F, Qu H, Li Y, et al. Relationship between serum secreted frizzled- related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance. Endocrinol J. 2015;62:733-740.
4. Mahdi T, Hanzelmann S, Salehi A, et al. Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab. 2012;16:625-633.
5. Taneera J, Lang S, Sharma A, et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012;16:122-134.
6. Valenzuela DM, Murphy AJ, Frendewey D, et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol. 2003;21:652-659.
7. Gusarova V, Alexa CA, Na E, et al. ANGPTL8/betatrophin does not control pancreatic β cell expansion. Cell. 2014;159:691-696.
8. Mastaitis J, Min S, Elvert R, et al. GPR17 gene disruption does not alter food intake or glucose homeostasis in mice. Proc Natl Acad Sci USA. 2015;112:1845-1849.
9. Hindson BJ, Ness KD, Masquelier DA, et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011;83:8604-8610.
10. Adams NC, Gale NW. High resolution gene expression analysis in mice using genetically instered reporter genes. In: Lois SPa C, ed. Mammalian and Avian Transgenesis-New Approaches. Berlin Heidelberg: Springer Verlag; 2006:131-172.
11. Shen Y, Yue F, McCleary DF, et al. A map of the cis-regulatory sequences in the mouse genome. Nature. 2012;488:116-120.
12. Tschop MH, Speakman JR, Arch JR, et al. A guide to analysis of mouse energy metabolism. Nat Methods. 2012;9:57-63.
13. Wolf SA, Steiner B, Akpinarli A, et al. CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J Immun. 2009;182:3979-3984.
14. Cousins RJ, Lanningham-Foster L. Regulation of cysteine-rich intestinal protein, a zinc finger protein, by mediators of the immune response. J Infect Dis. 2000;182(suppl 1):S81-S84.
15. Hoppmann N, Graetz C, Paterka M, et al. New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis. Brain. 2015;138:902-917.
16. Bangsow T, Baumann E, Bangsow C, et al. The epithelial membrane protein 1 is a novel tight junction protein of the blood-brain barrier. J Cereb Blood Flow Metab. 2008;28:1249-1260.
17. Nakanishi R, Shimizu M, Mori M, et al. Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice. J Bone Miner Res. 2006;21:1713-1721.
18. Nakanishi R, Akiyama H, Kimura H, et al. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass. J Bone Miner Res. 2008;23:271-277.
19. Cho HY, Choi HJ, Sun HJ, et al. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis. Bone. 2010;47:263-271.
20. Brommage R, Liu J, Hansen GM, et al. High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes. Bone Res. 2014;2:14034.
21. Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116:1202-1209.
22. Aslan H, Ravid-Amir O, Clancy BM, et al. Advanced molecular profiling in vivo detects novel function of dickkopf-3 in the regulation of bone formation. J Bone Miner Res. 2006;21:1935-1945.
23. Chung YS, Baylink DJ, Srivastava AK, et al. Effects of secreted frizzled-related protein 3 on osteoblasts in vitro. J Bone Miner Res. 2004;19:1395-1402.
24. Gordon A, Southam L, Loughlin J, et al. Variation in the secreted frizzled-related protein-3 gene and risk of osteolysis and heterotopic ossification after total hip arthroplasty. J Orthop Res. 2007;25: 1665-1670.
25. Oshima T, Abe M, Asano J, et al. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood. 2005;106:3160-3165.
26. Sathi GA, Inoue M, Harada H, et al. Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma. Oral Oncol. 2009;45:856-860.
27. Sharifi M, Ereifej L, Lewiecki EM. Sclerostin and skeletal health. Rev Endocrinol Metab Disord. 2015;16:149-156.
28. Kristensen IB, Christensen JH, Lyng MB, et al. Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease. Leukemia Lymphoma. 2014;55:911-919.
29. Lin C, Jiang X, Dai Z, et al. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/β-catenin signaling. J Bone Miner Res. 2009;24:1651-1661.
30. Economides AN, Frendewey D, Yang P, et al. Conditionals by inversion provide a universal method for the generation of conditional alleles. Proc Natl Acad Sci USA. 2013;110:E3179-E3188.
31. Barrantes Idel B, Montero-Pedrazuela A, Guadano-Ferraz A, et al. Generation and characterization of dickkopf3 mutant mice. Mol Cell Biol. 2006;26:2317-2326.
32. Morello R, Bertin TK, Schlaubitz S, et al. Brachy-syndactyly caused by loss of Sfrp2 function. J Cell Phys. 2008;217:127-137.
33. Lories RJ, Peeters J, Bakker A, Tylzanowski P, et al. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 2007;56:4095-4103.
34. Yu B, Chang J, Liu Y, et al. Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB. Nat Med. 2014; 20:1009-1017.
35. Garufi G, Seyhan AA, Pasarica M. Elevated secreted frizzled-related protein 4 in obesity: a potential role in adipose tissue dysfunction. Obesity. 2015;23:24-27.
36. Gauger KJ, Bassa LM, Henchey EM, et al. Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltration. PloS One. 2013;8:e78320.
37. Ouchi N, Higuchi A, Ohashi K, et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science. 2010;329:454-457.
38. Lee DA, Bedont JL, Pak T, et al. Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche. Nat Neurosci. 2012;15:700-702.
39. Kokoeva MV, Yin H, Flier JS. Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science. 2005;310:679-683.
40. Robins SC, Stewart I, McNay DE, et al. -Tanycytes of the adult hypothalamic third ventricle include distinct populations of FGFresponsive neural progenitors. Nat Commun. 2013;4:2049.
41. Wang X, Kopinke D, Lin J, et al. Wnt signaling regulates postembryonic hypothalamic progenitor differentiation. Dev Cell. 2012; 23:624-636.
42. Lie DC, Colamarino SA, Song HJ, et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature. 2005;437:1370-1375.
43. Muley A, Majumder S, Kolluru GK, et al. Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol. 2010;176:1505-1516.
44. Krutzfeldt J, Stoffel M. Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wildtype and obese mice. Diabetologia. 2010;53:123-127.
45. Rulifson IC, Karnik SK, Heiser PW, et al. Wnt signaling regulates pancreatic β cell proliferation. Proc Natl Acad Sci USA. 2007;104: 6247-6252.